Projects per year
Personal profile
Biography
John joined Alfred Health in October 2014 as the Scientific Director of the Biostatistics Consulting Platform in the Faculty of Medicine, Nursing and Health Sciences Monash University and The Alfred Hospital. From February 2022 he assumed the role of Senior Expert Biostatistician in the Department of Clinical Haematology at The Alfred. He obtained his PhD in Statistics, with a Minor in Genetics, from North Carolina State University (Raleigh). His experience, gained at Peter Mac, Novartis AG and Deakin University, lies mainly in the design and analysis of oncology clinical trials (all phases) but his early-career experience was gained in the design and analysis of experiments in the food and agricultural sciences.
Research interests
Web of Science Researcher ID: https://publons.com/researcher/2658815/john-reynolds/
Google Scholar: https://scholar.google.com.au/citations?hl=en&user=_pHSeSkAAAAJ
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
AAT-APP Trial: A RCT of alcohol approach-avoidance training to reduce heavy drinking in people with alcohol use disorders
Manning, V., Verdejo-Garcia, A., Lubman, D., Staiger, P. K., Garfield, J., Reynolds, J., de New, S., Wiers, R., Argent, A. & Clancy, C.
1/01/23 → 31/12/25
Project: Research
-
More efficient delivery of high-cost standard-of-care therapies in relapsed multiple myeloma using real-time feedback of patient-reported outcome measures: the MY-PROMPT-2 trial
Spencer, A., Rutherford, C., Reynolds, J., Ho, P. J., McQuilten, Z., Moore, E., King, T. A., Wood, E., Harrison, S. J. & Irving, A.
Department of Health and Aged Care (Australia)
1/02/22 → 31/01/27
Project: Research
-
INTERCEPT (Investigating Novel Therapy to target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): a multi-arm, precision-based, recursive, platform trial
Wei, A., DiNardo, C., Roberts, A. W., Daver, N., Reynolds, J., Blombery, P. A., Marlton, P. & Curtis, D.
1/07/21 → 30/06/25
Project: Research
-
Preventing infections in patients with blood cancer through evidence-based use of immunoglobulin or alternatives: The RATIONALISE trial
Wood, E., McQuilten, Z., Morrissey, O., Trotman, J., Spencer, A., Opat, S., Fanning, L., Reynolds, J., Paterson, D. & Mulligan, S. P.
1/07/21 → 30/06/26
Project: Research
-
A structured, telephone-delivered intervention to reduce methamphetamine use: study protocol for a parallel-group randomised controlled trial
Lubman, D. I., Manning, V., Arunogiri, S., Hall, K., Reynolds, J., Stragalinos, P., Petukhova, R., Gerhard, R., Tyler, J., Bough, A., Harris, A. & Grigg, J., 29 Mar 2023, In: Trials. 24, 1, 16 p., 235.Research output: Contribution to journal › Article › Other › peer-review
Open Access -
Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
Mithraprabhu, S., Reynolds, J., Turner, R., Quach, H., Horvath, N., Kerridge, I., Kalff, A., Bergin, K., Hocking, J., Yuen, F., Khong, T., Durie, B. M. & Spencer, A., 13 Feb 2023, In: Blood Cancer Journal. 13, 1, 5 p., 25.Research output: Contribution to journal › Letter › Other › peer-review
Open Access -
Alcohol use in the year following approach bias modification during inpatient withdrawal: secondary outcomes from a double-blind, multi-site randomized controlled trial
Manning, V., Garfield, J. B. B., Reynolds, J., Staiger, P. K., Piercy, H., Bonomo, Y., Lloyd-Jones, M., Jacka, D., Wiers, R. W., Verdejo-Garcia, A. & Lubman, D. I., 2022, (Accepted/In press) In: Addiction. 10 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Citations (Scopus) -
ALLG AMLM26 Phase 1B/2 Study Investigating Novel Therapies to Target Early Relapse and Clonal Evolution As Pre-Emptive Therapy in AML (INTERCEPT): A Multi-Arm, Precision-Based, Recursive, Platform Trial
Wei, A. H., Iland, H. J., Reynolds, J., Loo, S., Chua, C. C., Westerman, D. A., Tiong, I. S., Ivey, A., Blombery, P., Anstee, N. S., Koldej, R., Curtis, D. J., Kipp, D. A., Ritchie, D. S., Ross, D. M., Souza, A., Collins, J., Bajel, A., Grove, C. S., Marlton, P., & 7 others, 15 Nov 2022, In: Blood. 140, Suppl 1, p. 3341-3343 3 p.Research output: Contribution to journal › Meeting Abstract › peer-review
-
An intervention to improve the self-efficacy of key workers to support parental wellbeing at an early childhood intervention service in Australia: a stepped wedged randomized cluster trial
Young, D., Reynolds, J., Tonmukayakul, U., Carter, R., Swift, E., Williams, K., McDonald, R., Reddihough, D., Carracher, R., Ireland, P., Tracy, J., Kenyon, C. & Gibbs, L., Sep 2022, (Accepted/In press) In: Disability and Rehabilitation. 13 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
-
American Society of Hematology, Clinical Research Training Institute
John Reynolds (Invited speaker)
7 Mar 2023 → 9 Mar 2023Activity: Participating in or organising an event types › Contribution to workshop, seminar, course
-
iCMLf - CML Preceptorship 2019
John Reynolds (Invited speaker)
5 Sep 2019 → 6 Sep 2019Activity: Participating in or organising an event types › Contribution to workshop, seminar, course
-
Telethon Kids Institute (TKI) - Adaptive Health Intelligence - DSMC
John Reynolds (Member)
13 Oct 2017 → …Activity: External Academic Engagement › Committees and working groups
-
iCMLf - CML Preceptorship 2017
John Reynolds (Invited speaker)
31 Aug 2017 → 1 Sep 2017Activity: Participating in or organising an event types › Contribution to workshop, seminar, course
-
REMAP-CAP DSMB
John Reynolds (Member)
16 Feb 2016 → …Activity: External Academic Engagement › Committees and working groups